Halliburton Interest Paid increased by 11.8% to $114.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 1.7%, from $116.00M to $114.00M. Over 4 years (FY 2021 to FY 2025), Interest Paid shows a downward trend with a -4.4% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase in interest paid relative to debt levels may signal rising borrowing costs or higher leverage, while a decrease may indicate debt reduction or refinancing at lower rates.
The total cash outflow for interest payments on debt obligations, typically disclosed as a supplemental item in the cash...
Essential for comparing the cost of capital and debt burden across peers in the pharmaceutical industry.
interest_paid| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $123.00M | $141.00M | $115.00M | $134.00M | $110.00M | $140.00M | $103.00M | $127.00M | $101.00M | $127.00M | $105.00M | $118.00M | $100.00M | $118.00M | $105.00M | $116.00M | $98.00M | $116.00M | $102.00M | $114.00M |
| QoQ Change | — | +14.6% | -18.4% | +16.5% | -17.9% | +27.3% | -26.4% | +23.3% | -20.5% | +25.7% | -17.3% | +12.4% | -15.3% | +18.0% | -11.0% | +10.5% | -15.5% | +18.4% | -12.1% | +11.8% |
| YoY Change | — | — | — | — | -10.6% | -0.7% | -10.4% | -5.2% | -8.2% | -9.3% | +1.9% | -7.1% | -1.0% | -7.1% | +0.0% | -1.7% | -2.0% | -1.7% | -2.9% | -1.7% |